Azedra

Active Ingredient(s): Iobenguane I 131
FDA Approved: * July 30, 2018
Pharm Company: * PROGENICS PHARMA INC
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Azedra Overview

Iobenguane, or MIBG, is an aralkylguanidine analog of the adrenergic neurotransmitter norepinephrine and a radiopharmaceutical. It acts as a blocking agent for adrenergic neurons. When radiolabeled, it can be used in nuclear medicinal diagnostic techniques as well as in neuroendocrine antineoplastic treatments. It localizes to adrenergic tissue and thus can be used to identify the location of tumors such as pheochromocytomas and neuroblastomas. With I-131 it can also be used to eradicate tumo...

Read more Azedra Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Iobenguane

Recent Azedra Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Iobenguane I 131
  • Injection: 555mbq/ml(15mci/ml), 5ml
  • Solution: 10mci/5ml (2mci/ml), 15mci/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Azedra: (1 result)

Sorted by National Drug Code
  • 71258-015 Azedra 15 mci/Ml Intravenous Injection, Solution by Progenics Pharmaceuticals, Inc.

Other drugs which contain Iobenguane I 131 or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 13 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA